Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,691 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY Trials.
Gottenberg JE, Dörner T, Bootsma H, Devauchelle-Pensec V, Bowman SJ, Mariette X, Bartz H, Oortgiesen M, Shock A, Koetse W, Galateanu C, Bongardt S, Wegener WA, Goldenberg DM, Meno-Tetang G, Kosutic G, Gordon C. Gottenberg JE, et al. Among authors: gordon c. Arthritis Rheumatol. 2018 May;70(5):763-773. doi: 10.1002/art.40425. Epub 2018 Apr 12. Arthritis Rheumatol. 2018. PMID: 29381843 Free PMC article.
Candidate T cell epitopes of the human La/SSB autoantigen.
Davies ML, Taylor EJ, Gordon C, Young SP, Welsh K, Bunce M, Wordsworth BP, Davidson B, Bowman SJ. Davies ML, et al. Among authors: gordon c. Arthritis Rheum. 2002 Jan;46(1):209-14. doi: 10.1002/1529-0131(200201)46:1<209::AID-ART10066>3.0.CO;2-1. Arthritis Rheum. 2002. PMID: 11817592 Free article.
Lupus and zoster.
Douglas KM, Gordon C, Osman H, Heaton S, Skan J, Situnayake D, Bowman SJ. Douglas KM, et al. Among authors: gordon c. Lancet. 2003 Aug 23;362(9384):616. doi: 10.1016/S0140-6736(03)14192-X. Lancet. 2003. PMID: 12944061 No abstract available.
Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activity.
Yee CS, Farewell V, Isenberg DA, Prabu A, Sokoll K, Teh LS, Rahman A, Bruce IN, Griffiths B, Akil M, McHugh N, D'Cruz D, Khamashta MA, Bowman S, Maddison P, Zoma A, Allen E, Gordon C; British Isles Lupus Assessment Group. Yee CS, et al. Among authors: gordon c. Arthritis Rheum. 2006 Oct;54(10):3300-5. doi: 10.1002/art.22162. Arthritis Rheum. 2006. PMID: 17009266 Free article.
Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and atherosclerosis evaluation of risk (LASER) study.
Haque S, Gordon C, Isenberg D, Rahman A, Lanyon P, Bell A, Emery P, McHugh N, Teh LS, Scott DG, Akil M, Naz S, Andrews J, Griffiths B, Harris H, Youssef H, McLaren J, Toescu V, Devakumar V, Teir J, Bruce IN. Haque S, et al. Among authors: gordon c. J Rheumatol. 2010 Feb;37(2):322-9. doi: 10.3899/jrheum.090306. Epub 2009 Dec 1. J Rheumatol. 2010. PMID: 19955047
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.
Merrill JT, Neuwelt CM, Wallace DJ, Shanahan JC, Latinis KM, Oates JC, Utset TO, Gordon C, Isenberg DA, Hsieh HJ, Zhang D, Brunetta PG. Merrill JT, et al. Among authors: gordon c. Arthritis Rheum. 2010 Jan;62(1):222-33. doi: 10.1002/art.27233. Arthritis Rheum. 2010. PMID: 20039413 Free PMC article. Clinical Trial.
Systemic lupus erythematosus: clinical presentations.
Smith PP, Gordon C. Smith PP, et al. Among authors: gordon c. Autoimmun Rev. 2010 Nov;10(1):43-5. doi: 10.1016/j.autrev.2010.08.016. Epub 2010 Sep 17. Autoimmun Rev. 2010. PMID: 20850569 Review.
Systemic lupus and malignancies.
Bernatsky S, Kale M, Ramsey-Goldman R, Gordon C, Clarke AE. Bernatsky S, et al. Among authors: gordon c. Curr Opin Rheumatol. 2012 Mar;24(2):177-81. doi: 10.1097/BOR.0b013e32834ff258. Curr Opin Rheumatol. 2012. PMID: 22227880 Review.
Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study.
Wallace DJ, Kalunian K, Petri MA, Strand V, Houssiau FA, Pike M, Kilgallen B, Bongardt S, Barry A, Kelley L, Gordon C. Wallace DJ, et al. Among authors: gordon c. Ann Rheum Dis. 2014 Jan;73(1):183-90. doi: 10.1136/annrheumdis-2012-202760. Epub 2013 Jan 12. Ann Rheum Dis. 2014. PMID: 23313811 Free PMC article. Clinical Trial.
2,691 results